Vivencio Barrios

Summary

Country: Spain

Publications

  1. doi request reprint Can dabigatran improve blood pressure control?
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Future Cardiol 9:321-3. 2013
  2. ncbi request reprint Rosuvastatin and diabetes: when the evidences talk
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Cardiovasc Hematol Agents Med Chem 11:115-24. 2013
  3. doi request reprint Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:129-41. 2013
  4. doi request reprint New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Ctra de Colmenar Km 9, 100, Madrid, Spain
    Expert Opin Pharmacother 13:2649-61. 2012
  5. doi request reprint Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Cardiovasc Ther 26:2-9. 2008
  6. doi request reprint Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1609-18. 2010
  7. doi request reprint Antihypertensive and organ-protective effects of benazepril
    Vivencio Barrios
    Department of Cardiology, University Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1653-71. 2010
  8. ncbi request reprint [Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study]
    V Barrios
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Carretera de Colmenar, 28034 Madrid, Spain
    Rev Clin Esp 207:172-8. 2007
  9. ncbi request reprint Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Int J Clin Pract 59:1377-86. 2005
  10. ncbi request reprint [Cardiac protection as priority strategy of cardiovascular prevention in high blood pressure]
    V Barrios Alonso
    Instituto de Cardiologia, Hospital Ramon y Cajal, Madrid
    Rev Clin Esp 205:433-8. 2005

Collaborators

Detail Information

Publications81

  1. doi request reprint Can dabigatran improve blood pressure control?
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Future Cardiol 9:321-3. 2013
    ..In this report, the possible mechanisms that may explain this change are discussed...
  2. ncbi request reprint Rosuvastatin and diabetes: when the evidences talk
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Cardiovasc Hematol Agents Med Chem 11:115-24. 2013
    ..The risk of side effects is low, as is the risk of interactions with other drugs. In this manuscript, the efficacy and safety profile of rosuvastatin in diabetic population is reviewed...
  3. doi request reprint Rivaroxaban: a once-daily anticoagulant for the prevention of thromboembolic complications
    Vivencio Barrios
    Department of Cardiology, Hospital Universitario Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:129-41. 2013
    ..This article provides an extensive review of the available evidence about rivaroxaban, with a special focus on nonvalvular AF...
  4. doi request reprint New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Ctra de Colmenar Km 9, 100, Madrid, Spain
    Expert Opin Pharmacother 13:2649-61. 2012
    ..During past decades, vitamin K antagonists (warfarin or acenocoumarol) have been widely used for this purpose. However, they have several disadvantages that limit their daily use in clinical practice...
  5. doi request reprint Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Cardiovasc Ther 26:2-9. 2008
    ..8% vs. 3.6%). In conclusion, treatment with lercanidipine at high doses is associated with a lower rate of adverse events related to vasodilation compared to high doses of amlodipine or nifedipine GITS in clinical practice...
  6. doi request reprint Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1609-18. 2010
    ..In this article, available evidence about the efficacy and tolerability of the triple fixed combined therapy valsartan-amlodipine-hydrochlorothiazide for the treatment of hypertension is updated...
  7. doi request reprint Antihypertensive and organ-protective effects of benazepril
    Vivencio Barrios
    Department of Cardiology, University Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 8:1653-71. 2010
    ..Differences between combination therapies have implications for which patients may be best suited to particular interventions, and further studies are required to fully ascertain this potential...
  8. ncbi request reprint [Blood pressure and lipid control and coronary risk in the hypertensive population attended in Primary Care setting in Spain. The PRESCOT study]
    V Barrios
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Carretera de Colmenar, 28034 Madrid, Spain
    Rev Clin Esp 207:172-8. 2007
    ..Good blood pressure control was considered <140/90 mmHg (<130/80 mmHg for diabetics) and LDL-c according to the established by ATP-III for every risk group...
  9. ncbi request reprint Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease
    V Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Int J Clin Pract 59:1377-86. 2005
    ..EZE/SIMVA 10/20 mg produced superior lipid-altering efficacy by dual inhibition of cholesterol synthesis and intestinal absorption compared with doubling the dose of ATV from 10 to 20 mg...
  10. ncbi request reprint [Cardiac protection as priority strategy of cardiovascular prevention in high blood pressure]
    V Barrios Alonso
    Instituto de Cardiologia, Hospital Ramon y Cajal, Madrid
    Rev Clin Esp 205:433-8. 2005
    ..Consequently, the magnitude, etiological diversity, vulnerability and social-health care implications grant the intervention on cardiac protection a priority role in the management of HBP and its complications...
  11. ncbi request reprint [Adiponectin: an emerging cardiovascular risk factor. The REFERENCE Study]
    Vivencio Barrios
    Departamento de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol 61:1159-67. 2008
    ..This study investigated how the levels of adiponectin and other emerging risk factors are related to CV events in the Spanish population...
  12. ncbi request reprint Sex differences in the hypertensive population with chronic ischemic heart disease
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Clin Hypertens (Greenwich) 10:779-86. 2008
    ..BP and LDL-C control rates, although poor in both groups, were better in men (44.9% vs 30.5%, P<.001 and 33.0% vs 25.0%, P<.001, respectively). Stress testing and coronary angiography were more frequently performed in men...
  13. ncbi request reprint Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with the metabolic syndrome: data from the SARA Study
    Carlos Escobar
    Department of Cardiology, Hospital Ramon y Cajal, Carretera Colmenar km 9 100, Madrid, Spain
    J Clin Hypertens (Greenwich) 10:208-14. 2008
    ..5% (P=.01). The relative risk reduction of ECG-LVH was higher in patients with MS according to CorV and SokP criteria (P<.01)...
  14. ncbi request reprint Clinical profile and management of patients with chronic ischemic heart disease according to age in the population daily attended by cardiologists in Spain The ELDERCIC study
    Vivencio Barrios
    Vivencio Barrios, Dept of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Eur J Intern Med 21:180-4. 2010
    ..This study was aimed to evaluate the differences according to age in the clinical profile and management of outpatients with chronic ischemic heart disease attended by cardiologists in Spain...
  15. doi request reprint Gender differences in the diagnosis and treatment of left ventricular hypertrophy detected by different electrocardiographic criteria. Findings from the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Heart Vessels 25:51-6. 2010
    ..Although in daily clinical practice the use of both product criteria seemed clearly preferable to voltage for assessment of ECG-LVH, the CorP appeared to be markedly more useful in women and SokP in men...
  16. doi request reprint Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Renin Angiotensin Aldosterone Syst 10:168-73. 2009
    ..This study examined the influence of diabetes on left ventricular hypertrophy (LVH) detected by different electrocardiographic (ECG) criteria and its changes induced by a 12-month candesartan-based regimen...
  17. doi request reprint Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Drug Investig 29:427-39. 2009
    ....
  18. pmc Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Vasc Health Risk Manag 5:723-9. 2009
    ..This analysis assessed goal rate achievement in hypertensive patients receiving olmesartan-based treatment in the OLMEBEST study...
  19. ncbi request reprint Regression of left ventricular hypertrophy by a candesartan-based regimen in clinical practice. The VIPE study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, Madrid 28034, Spain
    J Renin Angiotensin Aldosterone Syst 7:236-42. 2006
    ..Thus, a candesartan-based regimen for six months significantly reduced echocardiographic LVH in hypertensive patients in general practice. The drug was very well tolerated and no serious adverse events were reported...
  20. ncbi request reprint Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study
    Alberto Calderon
    CS Rosa Luxemburgo, 5th Sanitary Area, Madrid, Spain
    Clin Exp Hypertens 32:145-53. 2010
    ..The combinations of the Cornell product with the Sokolow voltage or with the Sokolow product appear to be the most efficient options...
  21. ncbi request reprint Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Cardiometab Syndr 2:9-15. 2007
    ..5% for non-metabolic syndrome patients (P<.0001). These findings demonstrate that the metabolic syndrome is common in patients with hypertension and that it is generally poorly diagnosed and treated by primary care physicians...
  22. ncbi request reprint Blood pressure and lipid goal attainment in the hypertensive population in the primary care setting in Spain
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Clin Hypertens (Greenwich) 9:324-9. 2007
    ..The BP and LDL-C control rates in the hypertensive population attended to daily in primary care settings in Spain are low...
  23. doi request reprint Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial
    Vivencio Barrios
    Department of Cardiology, Hospital Ramón Cajal, Madrid, Spain
    Clin Ther 30:98-107. 2008
    ....
  24. ncbi request reprint Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone
    Hector F Escobar-Morreale
    Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain
    Ann Intern Med 142:412-24. 2005
    ..Substituting part of the dose of l-thyroxine with small but supraphysiologic doses of liothyronine in hypothyroid patients has yielded conflicting results...
  25. doi request reprint Patients with atrial fibrillation in a primary care setting: Val-FAAP study
    Vivencio Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Esp Cardiol (Engl Ed) 65:47-53. 2012
    ..To assess the clinical characteristics of patients with atrial fibrillation in the primary care setting...
  26. pmc Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Vasc Health Risk Manag 4:847-53. 2008
    ..The aim of this manuscript is to update the published data about the efficacy and safety of this fixed combination...
  27. doi request reprint Clinical profile and management of patients with hypertension and chronic ischemic heart disease according to BMI
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Obesity (Silver Spring) 18:2017-22. 2010
    ..03) and diabetes control (38.6% vs. 27.6% vs. 22.2%, P = 0.023). In conclusion, in patients with hypertension and chronic ischemic heart disease, as BMI increases, the clinical profile worsens as well as risk factors control rates...
  28. doi request reprint Pulse pressure and the metabolic syndrome in patients with hypertension
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Cardiometab Syndr 4:72-5. 2009
    ..The odds ratio of having high PP in women with MetS vs no MetS was 3.13 and in men was 1.9 (both P<.01)...
  29. ncbi request reprint Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Expert Opin Pharmacother 9:129-36. 2008
    ..5 mg is the latest combination of an angiotensin receptor blocker and a diuretic approved for treatment of hypertension. The aim of this manuscript is to update the published data about the efficacy and safety of this fixed combination...
  30. ncbi request reprint Candesartan: from left ventricular hypertrophy to heart failure, a global approach
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra Colmenar km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 5:825-34. 2007
    ....
  31. ncbi request reprint [Adequacy of the treatment of hypertensive patients with metabolic syndrome]
    Vivencio Barrios
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Madrid, Espana
    Med Clin (Barc) 128:647-51. 2007
    ....
  32. doi request reprint Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism
    Carlos Escobar
    Unidad de Ecocardiografía, Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:244-50. 2008
    ..The aim of this study was to determine the prognostic value of electrocardiography in hemodynamically stable patients with a diagnosis of acute symptomatic pulmonary embolism (PE)...
  33. doi request reprint An evaluation of the latest evidence relating to renin-angiotensin system inhibitors
    Carlos Escobar
    Hospital La Paz, Department of Cardiology, Madrid, Spain
    Expert Opin Drug Metab Toxicol 9:847-58. 2013
    ..In the last few years, a number of important clinical trials have been completed that have investigated the inhibition of the renin-angiotensin system. New drugs, focusing on this system, have now emerged as a result...
  34. doi request reprint Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid
    Cardiovasc Ther 28:295-301. 2010
    ..The aim of this review is to update information on the prevention of thromboembolic events in patients with AF and how dabigatran may change daily clinical practice...
  35. ncbi request reprint Effect of candesartan on coronary flow reserve in patients with systemic hypertension
    Juan Pablo Tomás
    Department of Cardiology, Ramon y Cajal Hospital, Madrid, Spain
    J Hypertens 24:2109-14. 2006
    ..The aim of this study was to evaluate, non-invasively, the effect of candesartan on coronary microvascular function in hypertensive patients...
  36. ncbi request reprint Prevalence of left ventricular hypertrophy detected by Cornell voltage-duration product in a hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 17:110-5. 2008
    ..g. Cornell voltage-duration product; CorP), is a good marker of LVH and the current study was designed to determine the prevalence of LVH in patients with essential hypertension treated in general practice...
  37. doi request reprint Diabetes and hypertension: which is the best approach?
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Expert Rev Cardiovasc Ther 7:269-71. 2009
    ..In this article the potential explanations of these results are discussed...
  38. ncbi request reprint Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Madrid 28034, Spain 34 91 336 8665
    Expert Opin Pharmacother 14:2249-61. 2013
    ..The aim of this article was to review the available evidence about this drug alone or combined with other antihypertensive agents in the treatment of hypertensive population...
  39. doi request reprint Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra de Colmenar km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 7:1317-27. 2009
    ..In this paper, the efficacy and safety of rosuvastatin along the cardiovascular continuum is reviewed...
  40. doi request reprint Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain
    Vivencio Barrios
    Cardiology Department, Hospital Ramon y Cajal, Madrid, Spain
    J Med Econ 15:45-54. 2012
    ....
  41. doi request reprint Beating the clock: reducing cardiovascular risk by rapid blood pressure reduction with olmesartan
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra de Colmenar Km 9, 100, 28034 Madrid, Spain
    Expert Opin Pharmacother 11:1549-58. 2010
    ....
  42. doi request reprint Aliskiren in the management of hypertension
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Am J Cardiovasc Drugs 10:349-58. 2010
    ..Moreover, this agent reduces plasma renin activity, which in theory could have additional clinical benefits. However, clinical trials analyzing the effects of aliskiren on mortality are still ongoing...
  43. ncbi request reprint [PREVENCAT study: control of cardiovascular risk in primary care]
    Luis A Alvarez-Sala
    Departamento de Medicina, Hospital General Universitario Gregorio Maranon, Facultad de Medicina, Universidad Complutense, Madrid, Spain
    Med Clin (Barc) 124:406-10. 2005
    ....
  44. pmc Relative safety profiles of high dose statin regimens
    Carlos Escobar
    Department of Cardiology, Hospital Ramon y Cajal Madrid, Spain
    Vasc Health Risk Manag 4:525-33. 2008
    ..During recent years, numerous trials to analyze the efficacy and tolerability of high doses of statins have been published. This paper updates the published data on the safety of statins at high doses...
  45. doi request reprint Diltiazem in the treatment of hypertension and ischemic heart disease
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 9:1375-82. 2011
    ..In this article, available evidence regarding diltiazem in the treatment of hypertension and ischemic heart disease is updated...
  46. ncbi request reprint Effectiveness of an Interventional Program to Improve Blood Pressure Control in Hypertensive Patients at High Risk for Developing Heart Failure: HEROIC study
    Beatriz de Rivas
    Medical Department, AstraZeneca, Madrid, Spain
    J Clin Hypertens (Greenwich) 12:335-44. 2010
    ..More complex and intensive programs are needed for this type of prevention...
  47. doi request reprint Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism
    David Jimenez
    Respiratory Department, Ramon y Cajal Hospital, IRYCIS, Madrid, Spain
    Thorax 66:75-81. 2011
    ....
  48. ncbi request reprint Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in daily clinical practice: the SARA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Hypertens 25:1967-73. 2007
    ..The aim of the SARA study was to investigate the effect of an ARB on electrocardiographic LVH (ECG-LVH) in a hypertensive outpatient population attending clinical practice...
  49. ncbi request reprint Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Clin Drug Investig 27:545-58. 2007
    ....
  50. ncbi request reprint N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 11:235-9. 2002
    ..This effect may be mediated by an NO-dependent mechanism, probably through the protective effect of NAC on NO oxidation...
  51. doi request reprint Low-dose fixed combination of perindopril plus indapamide in the diabetic hypertensive population
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Ctra, De Colmenar km 9, 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 6:1063-9. 2008
    ..Less than 85% of physicians considered the efficacy and tolerability of combined therapy as 'good' or 'very good' but 93% of the patients were 'satisfied' or 'very satisfied' with combined therapy...
  52. doi request reprint Combined therapy in the treatment of hypertension
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Fundam Clin Pharmacol 24:3-8. 2010
    ..In the present study, available evidence about the efficacy and tolerability of combined therapy for the treatment of hypertension is updated...
  53. ncbi request reprint [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia]
    Juan P Tomas
    Instituto de Enfermedades del Corazón, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol 57:909-15. 2004
    ..The aim of this study was to use this noninvasive technique to evaluate the effect of atorvastatin on peripheral endothelial function and on the coronary microvasculature in patients with dyslipidemia...
  54. doi request reprint Clinical applicability of B-type natriuretic peptide in patients with suspected heart failure in primary care in Spain: the PANAMA study
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Km 9 100, 28034 Madrid, Spain
    Expert Rev Cardiovasc Ther 9:579-85. 2011
    ..To assess the predictive value of B-type natriuretic peptide (BNP) in the diagnosis of heart failure (HF) in a primary-care setting in Spain...
  55. doi request reprint Candesartan in the treatment of hypertension: what have we learnt in the last decade?
    Vivencio Barrios
    Hospital Ramon y Cajal, Department of Cardiology, Madrid, Spain
    Expert Opin Drug Saf 10:957-68. 2011
    ....
  56. ncbi request reprint Aliskiren: a new drug for an old problem
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Carretera de Colmenar Viejo, Madrid, Spain
    Cardiovasc Hematol Agents Med Chem 8:1-10. 2010
    ..Aliskiren is a novel direct renin inhibitor with promising results. In this manuscript the current evidence about aliskiren, alone or in combination, is analyzed...
  57. ncbi request reprint Searching the place of pitavastatin in the current treatment of patients with dyslipidemia
    Vivencio Barrios
    Cardiology department Hospital Ramón y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 11:1597-612. 2013
    ..The aim of this review was to update the available evidence about efficacy and safety of pitavastatin, and to analyze the place of pitavastatin in the current armamentarium for the treatment of patients with hypercholesterolemia...
  58. doi request reprint Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Expert Rev Cardiovasc Ther 10:159-66. 2012
    ..Patients with left ventricular hypertrophy, diabetic nephropathy or microalbuminuria were more commonly treated with the combination of treatments...
  59. ncbi request reprint Importance of medication adherence from the ONTARGET and TRANSCEND points of view
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Fundam Clin Pharmacol 23:259-60. 2009
    ....
  60. doi request reprint Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    J Hypertens 26:2230-5. 2008
    ..The present study was designed to assess the influence of renal function on the clinical profile and management of the hypertensive outpatients with chronic ischemic heart disease...
  61. doi request reprint Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting
    Vivencio Barrios
    Cardiology Department, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 19:301-7. 2010
    ..To determine the proportion and clinical features of unrecognized heart failure (HF) in hypertensive women ≥65 years attended in Spain...
  62. ncbi request reprint Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE Study. Eficacia de Lercanidipino y su Perfil de Seguridad
    Vivencio Barrios
    Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Blood Press 11:95-100. 2002
    ..With the aim to determine the efficacy and tolerability of this drug in usual clinical practice we performed the ELYPSE trial...
  63. ncbi request reprint Sudden death after arteriovenous fistula ligation in a renal transplant patient
    Julio Pascual
    Department of Nephrology, Hospital Ramon y Cajal, Madrid, Spain
    Ann Vasc Surg 22:134-5. 2008
    ..We present a heart failure NYHA IV renal transplant patient with fatal evolution after surgical closure of her high-flow AV fistula...
  64. doi request reprint Adiponectin: An Emerging Cardiovascular Risk Factor. The REFERENCE Study
    Vivencio Barrios
    Departamento de Cardiologia, Hospital Ramon y Cajal, Madrid, Spain
    Rev Esp Cardiol (Engl Ed) 61:1159-67. 2008
    ..This study investigated how the levels of adiponectin and other emerging risk factors are related to CV events in the Spanish population...
  65. pmc Emerging drug combinations to optimize renovascular protection and blood pressure goals
    Carlos Escobar
    Department of Cardiology, Hospital Infanta Sofia, Madrid, Spain
    Int J Nephrol Renovasc Dis 5:69-80. 2012
    ..To date, RAS inhibitors recommended in this context are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Aliskiren, the first oral direct renin inhibitor available, has shown promising results...
  66. ncbi request reprint [Prognostic value of electrocardiographic findings in hemodynamically stable patients with acute symptomatic pulmonary embolism]
    Carlos Escobar
    Unidad de Ecocardiografía, Servicio de Cardiologia, Hospital Ramon y Cajal, Madrid, Espana
    Rev Esp Cardiol 61:244-50. 2008
    ..The aim of this study was to determine the prognostic value of electrocardiography in hemodynamically stable patients with a diagnosis of acute symptomatic pulmonary embolism (PE)...
  67. ncbi request reprint Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma
    José I Botella-Carretero
    Department of Endocrinology, Hospital Ramon y Cajal, Madrid, Spain
    Endocr Relat Cancer 11:345-56. 2004
    ....
  68. doi request reprint Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study
    Francisco J Félix-Redondo
    Centro de Salud Villanueva Norte, Villanueva de Serena, Badajoz, Spain
    J Hypertens 30:1460-7. 2012
    ..To determine the prevalence of left-ventricular hypertrophy (LVH) in the general population by means of multiple electrocardiographic criteria and those variables independently associated...
  69. pmc Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility
    Vivencio Barrios
    Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain
    Integr Blood Press Control 3:11-9. 2010
    ..The aim of this manuscript is to update the published data on the efficacy and safety of this fixed combination...
  70. ncbi request reprint [Hypertension and heart failure in Primary Care and Cardiology consultations of in Spain]
    V Barrios Alonso
    Sección de Hipertensión Arterial Sociedad Española de Cardiología, Madrid, Spain
    Rev Clin Esp 203:334-42. 2003
    ..Analyze the results concerning the heart failure population of CARDIOTENS 99, a cross-sectional study of hypertension associated with cardiovascular disease carried out on 32,051 patients seen in Cardiology and Primary Care consultations...
  71. ncbi request reprint Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice
    Vivencio Barrios
    Diabetes Res Clin Pract 77:492-3. 2007
  72. doi request reprint Concomitance of cardiovascular comorbidities in the hypertensive population: not only in the United States
    Vivencio Barrios
    Arch Intern Med 168:1350-1. 2008
  73. ncbi request reprint Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy
    Bjorn Dahlof
    University of Göteborg Ostra University Hospital, Goteborg, Sweden
    J Hypertens 20:1855-64. 2002
    ..To compare the effects of the angiotensin II antagonist, losartan, with those of atenolol on left ventricular hypertrophy (LVH), blood pressure and neurohormone concentrations in hypertensive patients with LVH...
  74. doi request reprint Gender differences in left ventricular hypertrophy regression
    Carlos Escobar
    Hypertension 51:e58; author reply e59. 2008
  75. ncbi request reprint [Blood pressure findings in Spanish dyslipidemic primary-care patients. LIPICAP-PA Study]
    Gustavo C Rodriguez-Roca
    Centro de Salud de La Puebla de Montalbán, Toledo, Spain
    Rev Esp Cardiol 60:825-32. 2007
    ..The aims of this study were to determine the blood pressure characteristics of dyslipidemic patients being treated in primary care, and to identify factors associated with poor blood pressure control...
  76. ncbi request reprint Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study
    Pablo Gomez
    Nephrology Department, Hospital del SAS, Jerez de la Frontera, Madrid, Spain 11407
    J Am Soc Nephrol 17:S194-200. 2006
    ..40; 95% CI 0.84 to 2.33). It was concluded that patients who have hypertension and visceral obesity and attend primary care present a higher prevalence of metabolic syndrome and RI...
  77. ncbi request reprint Evolution of blood pressure control in Spain
    Vivencio Barrios
    J Hypertens 25:1975-7. 2007
  78. ncbi request reprint [Clinical cardiology: update]
    Nekane Murga
    Hospital de Basurto, Bilbao, Espana
    Rev Esp Cardiol 61:86-96. 2008
    ..The review concludes with a summary of registry data collected in the last two years by the Clinical and Outpatient Cardiology Section of the Spanish Society of Cardiology...
  79. ncbi request reprint Rosuvastatin in older patients with systolic heart failure
    John Kjekshus
    Department of Cardiology, University of Oslo, Rikshospitalet University Hospital, Oslo, Norway
    N Engl J Med 357:2248-61. 2007
    ..Patients with systolic heart failure have generally been excluded from statin trials. Acute coronary events are uncommon in this population, and statins have theoretical risks in these patients...
  80. doi request reprint Importance of perception for blood pressure control
    Vivencio Barrios
    Arch Intern Med 168:1928; author replly 1929. 2008
  81. doi request reprint Gender and blood pressure control
    Vivencio Barrios
    Hypertension 51:e48; author reply e49. 2008